Nuventra, Inc. is a clinical pharmacology consulting firm specializing in pharmacokinetics (PK), pharmacodynamics (PD), and pharmacometrics (popPK). The pharmaceutical industry’s ‘go-to’ resource for PK/PD, Nuventra gives pharmaceutical companies and CROs rare access to a hands-on team of leading clinical pharmacology and PK/PD professionals experienced in a multitude of therapeutic areas and using leading PK/PD analysis software. We embrace the notion that simplicity and clarity lead to good decisions by taking complex pharmacokinetic principals and making them understandable and usable for common sense drug development. Nuventra’s flexible business structure enables our expert consultants to integrate within our clients’ R&D group and help them maximize the potential of clinical pharmacology studies and PK analyses to pave the way toward marketing approval.
Nuventra was founded in 2008 by Geoffrey Banks, Ph.D., (CEO) under the name ClinPharm Consulting, LLC. Dr. Banks formed a strategic partnership with Bill Wargin, Ph.D., (CSO), who is a leading pharmacokinetic consultant, and together they created the foundation for the company’s growth. Drs. Banks and Wargin realized that they had an extraordinary opportunity to create a consulting organization focused on an area of unmet need in the industry – clinical pharmacology and PK/PD. In developing the business paradigm, they recognized the benefits of having a team of industry veterans available for clients to address complex issues in clinical pharmacology and PK/PD.
Regulatory Document Preparation and Submission Services
Business Development, Marketing & Operations Services
Regulatory Review, Certification and Product Registration Services
Nuventra Pharma Sciences has not received any reviews.
Nuventra Pharma Sciences has not received any endorsements.